Mycenax Biotech Working Capital to Net Assets Ratio
Mycenax Biotech working capital to net assets ratio. Mycenax Biotech (4726) has a Working Capital to Net Assets ratio of -16.8% as of September 2025. Working capital of NT$-275.15 Million (current assets of NT$804.75 Million minus current liabilities of NT$1.08 Billion) is measured against net assets of NT$1.64 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check 4726 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Mycenax Biotech (2017–2024)
Working capital to net assets ratio of Mycenax Biotech from 2017 to 2024. This chart shows how Mycenax Biotech's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at -16.8%, reflecting working capital of NT$-275.15 Million against net assets of NT$1.64 Billion TWD. See Mycenax Biotech (4726) defensive interval to measure how many days the company can operate on defensive assets alone.
Mycenax Biotech Working Capital to Net Assets Ratio by Year (2017–2024)
Mycenax Biotech working capital to net assets ratio by year from 2017 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Mycenax Biotech from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 4726 asset base.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 3.7% | NT$74.89 Million | NT$2.02 Billion | NT$736.38 Million | NT$661.50 Million | ▼ -10.4 pp |
| 2023 | 14.1% | NT$344.59 Million | NT$2.45 Billion | NT$1.10 Billion | NT$753.42 Million | ▼ -27.4 pp |
| 2022 | 41.5% | NT$1.29 Billion | NT$3.11 Billion | NT$1.92 Billion | NT$634.73 Million | ▲ +22.8 pp |
| 2021 | 18.7% | NT$357.34 Million | NT$1.91 Billion | NT$897.41 Million | NT$540.07 Million | ▲ +6.2 pp |
| 2020 | 12.5% | NT$151.73 Million | NT$1.21 Billion | NT$576.51 Million | NT$424.78 Million | ▼ -11.3 pp |
| 2019 | 23.9% | NT$263.04 Million | NT$1.10 Billion | NT$494.96 Million | NT$231.91 Million | ▼ -7.6 pp |
| 2018 | 31.5% | NT$285.49 Million | NT$907.01 Million | NT$465.54 Million | NT$180.05 Million | ▼ -24.3 pp |
| 2017 | 55.8% | NT$637.91 Million | NT$1.14 Billion | NT$765.69 Million | NT$127.78 Million | — |